Last reviewed · How we verify

Iberet-Folic-500 — Competitive Intelligence Brief

Iberet-Folic-500 (Iberet-Folic-500) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hematinc supplement / Nutritional supplement. Area: Hematology / Nutritional deficiency.

marketed Hematinc supplement / Nutritional supplement Hematology / Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Iberet-Folic-500 (Iberet-Folic-500) — University of Malaya. Iberet-Folic-500 is a hematinc supplement combining iron and folic acid to treat and prevent nutritional anemia and folate deficiency.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Iberet-Folic-500 TARGET Iberet-Folic-500 University of Malaya marketed Hematinc supplement / Nutritional supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hematinc supplement / Nutritional supplement class)

  1. University of Malaya · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Iberet-Folic-500 — Competitive Intelligence Brief. https://druglandscape.com/ci/iberet-folic-500. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: